Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.
Medical Oncology clinical trials
Name: MK 6482
An Open-Label, Multicentre, Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab plus Lenvatinib in Combination with Belutifan in Multiple Solid Tumours.
Principal Investigator: Dr Matthew Wong
Study Coordinator: Cassandra Rubio
Condition: Endometrial Cancer
More information about MK 6482
For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see: